Skip to main content
editorial
. 2018 Jan 30;13:399–407. doi: 10.2147/COPD.S144312

Table 1.

Mucoactive drugs and their potential mechanism of action

Mucoactive drugs Potential mechanism of action
Expectorants
Hypertonic saline Increases secretion volume and/or hydration
Guaifenesin Stimulates secretion and reduces mucus viscosity
Mucus regulators
Carbocysteine Metabolism of mucus-producing cells, antioxidant and anti-inflammatory effects, modulates mucus production
Anticholinergic agents Decrease secretion volume
Glucocorticoids Reduce airway inflammation and mucin secretion
Macrolide antibiotics Reduce airway inflammation and mucin secretion
Mucolytics
N-acetylcysteine Breaks disulfide bonds linking mucin polymers, antioxidant and anti-inflammatory effects
Nacystelyn Increases chloride secretion and disulfide bonds
Erdosteine Modulates mucus production and increases mucociliary transport
Dornase alfa Hydrolyzes the DNA in mucus and reduces viscosity in the lungs
Gelsolin Severs actin filament cross-links
Thymosin β4 Severs actin filament cross-links
Dextran Breaks hydrogen bonds and increases secretion hydration
Heparin Breaks hydrogen bonds and ionic bonds
Mucokinetics
Bronchodilators Improve cough clearance by increasing expiratory flow
Surfactants Decrease sputum/mucus adhesiveness
Ambroxol Stimulates surfactant production and inhibits neuronal sodium channels

Note: Reproduced with permission from the © ERS 2010. European Respiratory Review Jun 2010, 19(116):127–133; DOI: 10.1183/09059180.00003510.43